Tessalon Perles (benzonatate) is used for the symptomatic relief of cough in adults and children 10 years of age and older. It is applied across therapeutic domains where additional symptomatic support is needed for patients experiencing symptoms related to physical discomfort.

The primary use is to help with a dry, non-productive cough associated with conditions such as the common cold, influenza, and acute bronchitis. The therapy is relevant for easing challenging symptoms, and it supports the patient by reducing the overall symptom load.

Tessalon Perles is particularly useful when symptoms become more disruptive during flare-ups and when the persistent cough interferes with routine activities, contributing to fatigue and difficulty sleeping. This supportive relief assists with maintaining functional stability and helps patients cope more steadily with symptom fluctuations. The medication is applied when symptoms related to heightened physiological activity become challenging, and supports symptomatic management during phases of increased distress.

Quick Fact: Relief for Disruptive Cough

Regulatory References

1. NIH DailyMed Drug Label

Eligibility Profile of Tessalon Perles (Benzonatate)

The official eligibility profile for Tessalon Perles, based on governmental regulatory documents, defines specific population exclusions and restrictions.

Age-Related and Safety Exclusions

The medicine is not approved for use in children younger than 10 years old. The safety and effectiveness in this age group have not been established. Regulatory authorities have issued warnings that accidental ingestion of even one or two capsules has resulted in serious toxicity, including death, in children under the age of 10.

Pregnancy and Lactation Status

Use during pregnancy is designated as Category C; the drug should be administered only if clearly needed and the potential benefit outweighs the potential risk. For nursing mothers, it is not known whether the medicine is excreted into human milk, and therefore, caution should be exercised.

Official Interaction Profile for Benzonatate

The interaction profile for benzonatate is based strictly on documentation from government health authorities, which highlights a specific pharmacodynamic risk and a structural chemical relationship. No substances or medicinal product classes are formally listed as contraindicated combinations in the regulatory prescribing information.

Regulatory Basis of Interaction Statements

The official prescribing information reports isolated instances where the co-administration of benzonatate with other prescribed medications resulted in severe psychiatric effects, specifically mental confusion and visual hallucinations. This pattern defines the core documented interaction in the regulatory literature. The drug is chemically related to the para-amino-benzoic acid class of anesthetic agents, such as procaine and tetracaine, and this structural relationship is noted as a precaution regarding potential CNS-related interactions. The regulatory documents do not contain documented pharmacokinetic interactions, such as enzyme-mediated changes in exposure or clearance, timing-based administration rules requiring dose separation, or specific restrictions concerning food, alcohol, or herbal products.

The pharmacodynamic action of Tessalon Perles, containing the compound benzonatate, is characterized by its function as a peripherally acting antitussive with local anesthetic properties. Its primary site of action involves the vagal afferent nerve fibers and the specialized pulmonary and pleural stretch receptors located throughout the lower respiratory tract, including the bronchi and lungs. Benzonatate interacts with these peripheral sensory nerve endings, likely by stabilizing their membranes and inhibiting the influx of sodium ions through voltage-gated channels. This local anesthetic effect dampens the excitability and reduces the sensitivity of the stretch receptors to mechanical stimuli. Consequently, the drug inhibits the generation of afferent nerve impulses that would normally travel along the vagus nerve to the central cough center situated in the medulla. By diminishing this crucial sensory input, benzonatate effectively interrupts the efferent motor cascade of the cough reflex arc at its origin, leading to a modulation of the system-level physiological response.

Benzonatate is administered exclusively by the oral route as a liquid-filled capsule, known as a Perle. This dosage form requires specific procedural care: the capsule must be swallowed whole, and it is explicitly stated that the capsule must not be broken, chewed, dissolved, cut, or crushed.

The standard administration regimen for adults and children 10 years of age and older is a single dose of 100 mg to 200 mg, taken up to three times a day as needed. It is a fundamental instruction that a patient must not exceed 200 mg in any single dose or a total of 600 mg within a 24-hour period. Benzonatate is available in 100 mg, 150 mg, and 200 mg strengths.

The usage schedule is determined by the return of symptoms. If a dose is missed, the official instruction is to skip the missed dose entirely and resume the normal schedule; two doses must never be taken simultaneously. The approved use is strictly limited to the defined age group, as efficacy and safety have not been established in children younger than 10 years. In the event of improper administration causing temporary numbness of the mouth or throat, patients are instructed to refrain from oral ingestion of food or liquids until this sensation resolves.

Recent Clinical Evidence Overview

Tessalon Perles (benzonatate) is a non-narcotic prescription medication approved for the symptomatic relief of cough in patients ten years of age and older. It acts peripherally by anesthetizing the stretch receptors in the respiratory passages, lungs, and pleura, thereby dampening the cough reflex. The onset of action is generally reported to be within 15 to 20 minutes, with effects lasting between 3 and 8 hours.

Limitations of Existing Evidence

Clinical data supporting the efficacy and safety of benzonatate primarily rely on studies conducted prior to current regulatory standards, including two small studies that led to its initial approval in 1958.

Recent systematic reviews (published through 2022) have highlighted substantial limitations in the current evidence base, noting concerns related to:

• Sample Size and Design: Initial studies involved very small populations and limited clinical settings, impacting the generalizability of the findings.
• Methodological Quality: Quality assessments often indicate high degrees of bias, suggesting a need for larger, well-designed randomized controlled trials (RCTs) to better characterize the drug’s role in modern medical practice.

Safety and Toxicity Focus

Recent research has focused less on efficacy trials and more on safety and toxicity, particularly in vulnerable populations.

These findings reinforce the need for strict adherence to prescription instructions and storage requirements to mitigate the risk of accidental exposure.

Common questions about Tessalon Perles (FAQ)

Q: What is the difference between Tessalon Perles and a cough syrup?

A: Tessalon Perles (benzonatate) is a prescription-only, non-narcotic antitussive. Its unique action is described as peripheral, meaning it works by creating a local numbing effect on cough receptors in the lungs and airways. This is distinct from many common over-the-counter cough syrups, which often act centrally on the brain or contain combination ingredients like expectorants or decongestants.

Q: Can Tessalon Perles be used for any type of cough?

A: According to official product information, benzonatate is indicated for the symptomatic relief of cough. Regulatory labels focus on treating the symptom of cough rather than restricting use based on whether the cough is described as dry, wet, or productive.

Q: Why are the pills shaped like clear, yellow beads?

A: Tessalon Perles is formulated as a liquid-filled, soft gelatin capsule, commonly referred to as a 'Perle.' The characteristic yellow color comes from inactive ingredients, such as D&C Yellow No. 10, which is included in the composition of the capsule shell.

Q: Is it safe to use Tessalon Perles with common pain relievers like Tylenol or Advil?

A: Official regulatory documents do not provide specific data or warnings regarding co-administration with non-prescription pain relievers (such as acetaminophen or ibuprofen). However, the label reports isolated instances of psychiatric effects, including mental confusion, when benzonatate is taken in combination with other prescribed drugs.

Q: What should I do if I accidentally take more Tessalon Perles than intended?

A: Overdose symptoms can occur rapidly, often within 15 to 20 minutes, and may result in serious adverse events, including death, particularly in children. Regulatory documents state that if accidental ingestion or overdose is suspected, emergency medical services should be contacted.

Q: Can Tessalon Perles be used for a cough caused by allergies?

A: Yes, the regulatory indications state that the medication is for the symptomatic relief of cough. The label focuses on treating the cough symptom itself rather than restricting use based on the underlying cause, such as an allergy or infection.

Q: Is there a generic version available for Tessalon Perles?

A: Yes. Tessalon Perles is a brand name for the active ingredient, benzonatate. This medication is widely available under its generic name as Benzonatate Capsules, USP.

Q: Does Tessalon Perles have an expiration date?

A: Like all prescription medications, Tessalon Perles has an expiration date printed on the packaging by the manufacturer. Federal disposal guidelines recommend that unused or expired medication be handled according to local waste management policies, which may include a drug take-back program.

Q: Can this medication affect my blood pressure?

A: Severe hypersensitivity reactions are noted in regulatory documents, typically associated with improper use like chewing or sucking the capsule. These rare, serious reactions have been reported to include cardiovascular collapse, which is a severe drop in blood flow and blood pressure.

Q: Does Tessalon Perles help with chest congestion or only a dry cough?

A: Tessalon Perles is classified strictly as an antitussive (cough suppressant) and is indicated only for the relief of the cough symptom itself. Official product information confirms it does not contain an expectorant or decongestant to actively treat chest congestion.

Q: Can this drug be taken with cold and flu medicine?

A: Regulatory information reports psychiatric effects when benzonatate is taken in combination with other prescribed drugs. Caution is exercised when benzonatate is co-administered with other central nervous system depressants (which can include some cold/flu remedies), as this may potentiate effects like sedation.

Q: Is Tessalon Perles generally considered safe for older adults?

A: The official label does not contain specific safety data or require dose adjustments solely for geriatric patients. The standard adult dose is used for all patients ten years of age and older.

Q: Does Tessalon Perles have weight restrictions for use?

A: The dosage is prescribed in milligrams (mg) based on symptom severity and is not generally determined by a patient’s weight. Regulatory labels for adults do not specify weight-based dosing or restrictions.

Q: Can I use this medicine if I have asthma or COPD?

A: The regulatory label notes that severe hypersensitivity reactions from improper use (chewing or sucking) can include bronchospasm (airway tightening). However, official product information does not list pre-existing asthma or COPD as a formal contraindication to the use of benzonatate.

Q: Does Tessalon Perles interfere with blood thinners?

A: Official regulatory documents do not list specific drug classes, such as blood thinners (anticoagulants), as having known pharmacokinetic interactions. However, the label notes that severe psychiatric effects, such as mental confusion and visual hallucinations, have been reported when benzonatate is co-administered with other prescribed drugs.

Q: Is it okay to stop taking Tessalon Perles suddenly?

A: Benzonatate is a non-narcotic medication used for the symptomatic relief of cough and is generally taken only as needed. Official sources confirm that it is not associated with withdrawal symptoms when treatment is stopped.

Q: Is this a long-term medication, or is it only for short-term use?

A: The medication is approved for the symptomatic relief of cough and is typically prescribed for short-term use, taken only as needed. Regulatory documents state that if the cough persists for more than 7 days, tends to recur, or is accompanied by fever or rash, a healthcare provider should be consulted.

Q: Can Tessalon Perles be taken on an empty stomach?

A: Yes, official patient information sources generally confirm that benzonatate can be taken with or without food as directed by a healthcare professional.

Q: Are there special precautions for people with kidney or liver issues?

A: Official regulatory prescribing information does not contain data or specific dose adjustments for patients with pre-existing renal (kidney) or hepatic (liver) impairment.

Q: Is there a risk of choking if the pearl gets stuck in the throat?

A: The official label warns that if the capsule is broken, chewed, or sucked, the local anesthetic effect on the throat could cause numbness. This numbness could lead to difficulty swallowing, and the label notes that choking could occur as a result of this effect.

Q: Does Tessalon Perles contain any common allergens like gluten or lactose?

A: Official regulatory labels list the inactive ingredients, which include components like gelatin and glycerin. They do not list gluten or lactose among the inactive ingredients for benzonatate capsules.

Q: Can Tessalon Perles affect the results of any medical tests?

A: The official regulatory prescribing information does not contain any documented interference with medical or laboratory test results.

Q: What are the signs of a severe allergic reaction to the drug?

A: Official documents state that signs of a severe allergic reaction may include rash, hives, itching, tightening of the throat, difficulty breathing or swallowing, numbness of the chest, and cardiovascular collapse. The presence of these serious symptoms necessitates contact with emergency medical services.

Q: Why is Tessalon Perles sometimes prescribed for post-viral coughs?

A: Benzonatate is a cough suppressant indicated for the symptomatic relief of cough. Since post-viral coughs can often be chronic, dry, and highly irritating, the medication's mechanism of numbing the cough receptors is used to interrupt that persistent cough reflex.

Q: Are there any contraindications related to mental health conditions?

A: While the official product label does not list a mental health condition as a formal contraindication, it does report psychiatric effects, such as mental confusion and visual hallucinations, when taken in combination with other prescribed drugs.

Storage and Disposal Requirements

Official labeling defines strict conditions for storing and disposing of Tessalon Perles (benzonatate).

Storage Conditions

Child Safety and Disposal

Pharmacists are required to dispense the medication in a child-resistant container. The medicine must be stored strictly out of the reach of children and pets at all times, as accidental ingestion can lead to death.

To dispose of unused or expired product, the Federal Drug Disposal Guidelines recommend using a medicine take-back program. If a take-back option is unavailable, the product should be mixed with an undesirable substance (such as cat litter or used coffee grounds), sealed in a container, and placed in the household trash. Do not flush Tessalon Perles down the toilet.